| 000 | 01845 a2200589 4500 | ||
|---|---|---|---|
| 005 | 20250518061018.0 | ||
| 264 | 0 | _c20200511 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1421-9786 | ||
| 024 | 7 |
_a10.1159/000501957 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Guangli | |
| 245 | 0 | 0 |
_aRenal Function Affects Prognostic Role of Antiphosphatidylserine Antibodies for Acute Ischemic Stroke Patients. _h[electronic resource] |
| 260 |
_bCerebrovascular diseases (Basel, Switzerland) _c2019 |
||
| 300 |
_a1-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Antiphospholipid _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBrain Ischemia _xblood |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 | _aDisability Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xphysiopathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhosphatidylserines _ximmunology |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aStroke _xblood |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aZhong, Chongke | |
| 700 | 1 | _aPeng, Hao | |
| 700 | 1 | _aBu, Xiaoqing | |
| 700 | 1 | _aWang, Aili | |
| 700 | 1 | _aXu, Tian | |
| 700 | 1 | _aPeng, Yanbo | |
| 700 | 1 | _aXu, Tan | |
| 700 | 1 | _aLi, Qunwei | |
| 700 | 1 | _aJu, Zhong | |
| 700 | 1 | _aGeng, Deqin | |
| 700 | 1 | _aChen, Jing | |
| 700 | 1 | _aZhang, Yonghong | |
| 700 | 1 | _aHe, Jiang | |
| 773 | 0 |
_tCerebrovascular diseases (Basel, Switzerland) _gvol. 48 _gno. 1-2 _gp. 1-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000501957 _zAvailable from publisher's website |
| 999 |
_c30105255 _d30105255 |
||